VAMP2 decreases 5-HT uptake and SERT cell surface expression in HEK-293 MSR cells by reducing the delivery rate of the transporter to the plasma membrane. by Heidi Kaastrup Müller (570207)

TGF-β1 decreases RECK expression in fibroblasts. by Jaime Gutiérrez (401710)

Receptor specific silencing decreases NGF induced apoptosis. by Alessandra Micera (294762)

“…A 37.5%-decrease (*) and a 50%-decrease (**) of apoptotic signal were detected respectively in p75^NTR-siRNA and p75^NTR/trkA^NGFR-siRNA (p<.05).…”

<i>ism1</i> knockdown decreases erythrocytes. by Arturo Berrun (5216003)

Cytokine dependent decrease in vSMC viability after type I NKT cell activation. by Gijs H. M. van Puijvelde (500345)

Inhibition of Hh signaling decreases hMSC proliferation. by Magali Plaisant (230886)

IGF-1 injections significantly attenuate the increase in CD4+CD8+ double positive T cells seen at day 30 after IR. by Jordan A. Gunning (18143970)

Subjects:

Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

“…Cell stiffness was measured before and after the nanorobotic surgery and decreases from 30.0±1.5 kPa to 20.5±2.8 kPa, respectively. …”

Chemotherapy decreases cell proliferation in the adult mouse CNS by Joerg Dietrich (35101)

Rabankyrin-5 Overexpression Increases, whereas Knock-Down Decreases Fluid-Phase Uptake, Specifically by Carsten Schnatwinkel (48)

Dysfunction of <i>ERG251</i> activates a Zinc transporter contributing to decreased azole susceptibility. by Xin Zhou (54275)

(R)-albuterol decreases cytokine mRNA levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

PV1-treated mice exhibited a decrease in overall activation of T lymphocytes. by Pedro Henrique Papotto (791904)

PTH decreased cell apoptosis in a Flt-3L expanded population. by Flavia Q. Pirih (360515)

PSMα3N22Y shows decreased activation of FPR1. by Gordon Y. C. Cheung (337723)

HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…However, transfection of SUZ12 siRNA significantly reduced endothelial branching compared to HG+control siRNA. [NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”

Example of calculating the area under the threshold of the serum albumin curve up to postoperative day 5 (preset threshold = 3.0 g/dL). by Yoonjee Cho (15453454)

High fat diet decreased tumor latency but did not affect survival in MMTV-PyMT transgenic mice. by Katherine V. Clark-Knowles (368164)

IL-18 increases expression of MLCK and pMLC via ROCK, and decreases that of phosphorylated STAT-5. by Ossama Allam (5043434)

CK2α decreases CLK transcription factor activity. by Áron Szabó (450885)